An official website of the United States government
Publications
2024
Jiaqi Huang, Hadijah Nabalende, M Constanza Camargo, et al. Plasma metabolites in childhood Burkitt lymphoma cases and cancer-free controls in Uganda. Metabolomics. 2024 Jun 28;20(4):67.
Liu Z, Luo Y, Kirimunda S, et al. Human leukocyte antigen-DQA1*04:01 and rs2040406 variants are associated with elevated risk of childhood Burkitt lymphoma. Commun Biol. 2024 Jan 5;7(1):41.
2023
Baker FS, Wang J, Vargas OF, et al. IFNL4 Genotypes and Risk of Childhood Burkitt Lymphoma in East Africa J Interferon Cytokine Res. 2023 Jun 27. Epub ahead of print.
Broen K, Dickens J, Trangucci R. Burkitt lymphoma risk shows geographic and temporal associations with Plasmodium falciparum infections in Uganda, Tanzania, and Kenya. Proc Natl Acad Sci U S A. 2023 Jan 10;120(2):e2211055120. Epub 2023 Jan 3.
Hong HG, Gouveia MH, Ogwang MD, et al. Sickle cell allele HBB-rs334(T) is associated with decreased risk of childhood Burkitt lymphoma in East Africa. Am J Hematol. 2023 Nov 27. Epub ahead of print.
Zhou W, Fischer A, Ogwang MD, et al. Mosaic chromosomal alterations in peripheral blood leukocytes of children in sub-Saharan Africa. Nat Commun. 2023 Dec 6;14(1):8081.
2022
Liao H, Liu H, Chin P, et al. Epstein-Barr Virus in Burkitt Lymphoma in Africa Reveals a Limited Set of Whole Genome and LMP-1 Sequence Patterns: Analysis of Archival Datasets and Field Samples From Uganda, Tanzania, and Kenya Front Oncol. 2022 Mar 7;12:812224.
López C, Burkhardt B, Chan JKC, Leoncini L, Mbulaiteye SM, Ogwang MD, Orem J, Rochford R, Roschewski M, Siebert R. Burkitt Lymphoma. Nat Rev Dis Primers. 2022 Dec 15;8(1):78.
Mbulaiteye S, Devesa S. Burkitt Lymphoma Incidence in Five Continents
Hemato. 2022 Jul;3(3), 434-453.
Thomas N, Dreval K, Gerhard DS, et al. Genetic Subgroups Inform on Pathobiology in Adult and Pediatric Burkitt Lymphoma. Blood. 2022 Oct 6. Epub ahead of print.
2021
Arisue N, Chagaluka G, Palacpac NMQ, et al. Assessment of Mixed Plasmodium falciparum sera5 Infection in Endemic Burkitt Lymphoma: A Case-Control Study in Malawi Cancers (Basel). 2021 Apr 2;13(7):1692.
Peprah S, Ogwang MD, Kerchan P, et al. Inverse association of falciparum positivity with endemic Burkitt lymphoma is robust in analyses adjusting for pre-enrollment malaria in the EMBLEM case-control study Infect Agent Cancer. 2021 Jun 7;16(1):40.
Xian R, Kinyear T, Otim I, et al. Plasma EBV DNA: A Promising Diagnostic Marker for Endemic Burkitt Lymphoma Front Oncol. 2021 Dec 14;11:804083.
2020
Gouveia MH, Borda V, Leal TP, et al. Origins, admixture dynamics and homogenization of the African gene pool in the Americas. Mol Biol Evol. 2020 Mar 3. [Epub ahead of print]
Kirimunda S, Verboom M, Otim I, et al. Variation in the Human Leukocyte Antigen system and risk for endemic Burkitt lymphoma in northern Uganda. Br J Haematol 2020 Feb 18.
Mateus H Gouveia, Isaac Otim, Martin D Ogwang, et al. Endemic Burkitt Lymphoma in second-degree relatives in Northern Uganda: in-depth genome-wide analysis suggests clues about genetic susceptibility.Leukemia 2020 Oct 13;146(4):953-969. [Epub ahead of print]
Peprah S, Ogwang MD, Kerchan P, et al. Mean platelet counts are relatively decreased with malaria but relatively increased with Endemic Burkitt lymphoma in Uganda, Tanzania, and Kenya. Br J Haematol 2020 May 12. [Epub ahead of print]
Peprah S, Ogwang MD, Kerchan P, et al. Risk factors for Burkitt lymphoma in East African children and minors: A case-control study in malaria-endemic regions in Uganda, Tanzania and Kenya. Int J Cancer 2020 Feb 15;146(4):953-969.
Redmond LS, Ogwang MD, Kerchan P, et al. Endemic Burkitt lymphoma: a complication of asymptomatic malaria in sub-Saharan Africa based on published literature and primary data from Uganda, Tanzania, and Kenya. Malar J. 2020;19(1):239.
2019
Derkach A, Otim I, Pfeiffer RM, et al. Associations between IgG reactivity to Plasmodium falciparum erythrocyte membrane protein 1 (PfEMP1) antigens and Burkitt lymphoma in Ghana and Uganda case-control studies. EBioMedicine 2019 Jan;39:358-368.
Grande BM, Gerhard DS, Jiang A, et al. Genome-wide discovery of somatic coding and noncoding mutations in pediatric endemic and sporadic Burkitt lymphoma. Blood 2019 Mar 21;133(12):1313-1324.
Gouveia MH, Bergen AW, Borda V, et al. Genetic signatures of gene flow and malaria-driven natural selection in sub-Saharan populations of the "endemic Burkitt Lymphoma belt". PLoS Genet 2019 Mar 8;15(3):e1008027. eCollection 2019 Mar.
Peprah S, Dhudha H, Ally H, et al. A population-based study of the prevalence and risk factors of low-grade Plasmodium falciparum malaria infection in children aged 0-15 years old in northern Tanzania. Trop Med Int Health 2019 Mar 7. [Epub ahead of print]
Peprah S, Tenge C, Genga IO, et al. A Cross-Sectional Population Study of Geographic, Age-Specific, and Household Risk Factors for Asymptomatic Plasmodium falciparum Malaria Infection in Western Kenya. Am J Trop Med Hyg 2019 Jan;100(1):54-65.
2018
Liao HM, Liu H, Lei H, et al. Frequency of EBV LMP-1 Promoter and Coding Variations in Burkitt Lymphoma Samples in Africa and South America and Peripheral Blood in Uganda. Cancers (Basel). 2018 Jun 2;10(6). pii: E177.
Maziarz M, Nabalende H, Otim I, et al. A cross-sectional study of asymptomatic Plasmodium falciparum infection burden and risk factors in general population children in 12 villages in northern Uganda. Malar J 2018 Jun 20;17(1):240.
Mbulaiteye SM, Anderson WF. Age-related heterogeneity of Burkitt lymphoma. Br J Haematol 2018 Jan;180(1):153-155.
Ravell J, Otim I, Nabalende H, et al. Plasma magnesium is inversely associated with Epstein-Barr virus load in peripheral blood and Burkitt lymphoma in Uganda. Cancer Epidemiol 2018 Feb;52:70-74. Erratum in: Cancer Epidemiol. 2018 Aug;55:192.
2017
Agerbaek MØ, Pereira MA, Clausen TM, et al. Burkitt lymphoma expresses oncofetal chondroitin sulfate without being a reservoir for placental malaria sequestration. Int J Cancer 2017 Apr 1;140(7):1597-1608.
Legason ID, Pfeiffer RM, Udquim KI, et al. Evaluating the Causal Link Between Malaria Infection and Endemic Burkitt Lymphoma in Northern Uganda: A Mendelian Randomization Study. EBioMedicine 2017 Nov;25:58-65.
Lombardo KA, Coffey DG, Morales AJ, et al. High-throughput sequencing of the B-cell receptor in African Burkitt lymphoma reveals clues to pathogenesis. Blood Adv 2017 Mar 21;1(9):535-544. eCollection 2017 Mar 28.
Maziarz M, Kinyera T, Otim I, et al. Age and geographic patterns of Plasmodium falciparum malaria infection in a representative sample of children living in Burkitt lymphoma-endemic areas of northern Uganda. Malar J 2017 Mar 20;16(1):124.
2016
Linet MS, Brown LM, Mbulaiteye SM, et al. International long-term trends and recent patterns in the incidence of leukemias and lymphomas among children and adolescents ages 0-19 years. Int J Cancer 2016 Apr 15;138(8):1862-74.
2015
Lei H, Li T, Li B, et al. Epstein-Barr virus from Burkitt Lymphoma biopsies from Africa and South America share novel LMP-1 promoter and gene variations. Sci Rep 2015 Nov 23;5:16706.
2014
Adewole I, Martin DN, Williams MJ, et al. Building capacity for sustainable research programmes for cancer in Africa. Nat Rev Clin Oncol 2014 May;11(5):251-9. Review.
Aka P, Emmanuel B, Vila MC, et al. Elevated serum levels of interleukin-6 in endemic Burkitt lymphoma in Ghana. Hematol Oncol 2014 Dec;32(4):218-20.
Johnston WT, Mutalima N, Sun D, et al. Relationship between Plasmodium falciparum malaria prevalence, genetic diversity and endemic Burkitt lymphoma in Malawi. Sci Rep 2014 Jan 17;4:3741.
Mbulaiteye SM, Morton LM, Sampson JN, et al. Medical history, lifestyle, family history, and occupational risk factors for sporadic Burkitt lymphoma/leukemia: the Interlymph Non-Hodgkin Lymphoma Subtypes Project. J Natl Cancer Inst Monogr 2014 Aug;2014(48):106-14.
Mbulaiteye SM, Pullarkat ST, Nathwani BN, et al. Epstein-Barr virus patterns in US Burkitt lymphoma tumors from the SEER residual tissue repository during 1979-2009. APMIS 2014 Jan;122(1):5-15.
Simbiri KO, Biddle J, Kinyera T, et al. Burkitt lymphoma research in East Africa: highlights from the 9(th) African organization for research and training in cancer conference held in Durban, South Africa in 2013. Infect Agent Cancer 2014 Sep 11;9:32. eCollection 2014.
Williams CK, Cristina Stefan D, Rawlinson F, et al. The African Organisation for Research and Training in Cancer and its conferences: a historical perspective and highlights of the Ninth International Conference, Durban, South Africa, 21-24 November 2013. Ecancermedicalscience 2014 Feb 3;8:396. eCollection 2014.
2013
Aka P, Vila MC, Jariwala A, et al. Endemic Burkitt lymphoma is associated with strength and diversity of Plasmodium falciparum malaria stage-specific antigen antibody response. Blood 2013 Aug 1;122(5):629-35.
Mbulaiteye SM, Clarke CA, Morton LM, et al. Burkitt lymphoma risk in U.S. solid organ transplant recipients. Am J Hematol 2013 Apr;88(4):245-50.
2012
Aka P, Kawira E, Masalu N, et al. Incidence and trends in Burkitt lymphoma in northern Tanzania from 2000 to 2009. Pediatr Blood Cancer 2012 Dec 15;59(7):1234-8.
Baik S, Mbaziira M, Williams M, et al. A case-control study of Burkitt lymphoma in East Africa: are local health facilities an appropriate source of representative controls? Infect Agent Cancer 2012 Mar 13;7(1):5.
Guech-Ongey M, Yagi M, Palacpac NM, et al. Antibodies reactive to Plasmodium falciparum serine repeat antigen in children with Burkitt lymphoma from Ghana. Int J Cancer 2012 Apr 15;130(8):1908-14.
Mbulaiteye SM, Anderson WF, Ferlay J, et al. Pediatric, elderly, and emerging adult-onset peaks in Burkitt's lymphoma incidence diagnosed in four continents, excluding Africa. Am J Hematol 2012 Jun;87(6):573-8.
Schmitz R, Young RM, Ceribelli M, et al. Burkitt lymphoma pathogenesis and therapeutic targets from structural and functional genomics. Nature 2012 Oct 4;490(7418):116-20.
2011
Emmanuel B, Kawira E, Ogwang MD, et al. African Burkitt lymphoma: age-specific risk and correlations with malaria biomarkers. Am J Trop Med Hyg 2011 Mar;84(3):397-401.
Ogwang MD, Zhao W, Ayers LW, Mbulaiteye SM. Accuracy of Burkitt lymphoma diagnosis in constrained pathology settings: importance to epidemiology. Arch Pathol Lab Med 2011 Apr;135(4):445-50.
2010
Mbulaiteye SM, Anderson WF, Bhatia K, et al. Trimodal age-specific incidence patterns for Burkitt lymphoma in the United States, 1973-2005. Int J Cancer 2010 Apr 1;126(7):1732-9.
Mbulaiteye SM, Talisuna AO, Ogwang MD, et al. African Burkitt's lymphoma: could collaboration with HIV-1 and malaria programmes reduce the high mortality rate? Lancet 2010 May 8;375(9726):1661-3.
2009
Mbulaiteye SM, Biggar RJ, Bhatia K, et al. Sporadic childhood Burkitt lymphoma incidence in the United States during 1992-2005. Pediatr Blood Cancer 2009 Sep;53(3):366-70.
2008
Ogwang MD, Bhatia K, Biggar RJ, et al. Incidence and geographic distribution of endemic Burkitt lymphoma in northern Uganda revisited. Int J Cancer 2008 Dec 1;123(11):2658-63. [View Abstract]